Price $9.25 |
Market Cap
54.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.5
|
P/B
-
|
P/S
2.06
|
Dividend %
-
|
|
P/CF
16.2
|
P/FCF
8.8
|
Op. Cash Flow
7K
|
FCF
0.8
|
|
Op. Margin
18.70%
|
Net Margin
-2.70%
|
ROE
5.10%
|
ROI
-128.80%
|
|
ROA
-3.20%
|
EPS Growth
-11.00%
|
Current Ratio
0.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $0.39 | - | - | 27.8M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 12M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
